First human tests begin for new drug formulation
NCT ID NCT06932536
Summary
This study tested how a new drug formulation called SR750 is processed by the body and checked its safety in healthy volunteers. Forty healthy Chinese adults received either the drug or a placebo to measure how their bodies absorbed and cleared it. The main goal was to gather early safety data and understand how the drug behaves in people before testing it in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU)
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.